|1.||Motyl, T: 1 article (01/2011)|
|2.||Król, M: 1 article (01/2011)|
|3.||Dolka, I: 1 article (01/2011)|
|4.||Szyszko, K: 1 article (01/2011)|
|5.||Majchrzak, K: 1 article (01/2011)|
|6.||Abramowicz, A: 1 article (01/2011)|
|7.||Pawłowski, K M: 1 article (01/2011)|
|8.||Malhotra, A K: 1 article (06/2007)|
|9.||Kucherlapati, R: 1 article (06/2007)|
|10.||Morgan, T V: 1 article (06/2007)|
01/01/2011 - "This is the first study performed to asses if the number of TAMs and expression of MCSF-R (macrophages colony stimulating factor receptor) and CD14 (LPS co-receptor) are associated with the grade of tumor malignancy and its ability to metastasize. "
04/26/2004 - "Elevated coexpression of colony-stimulating factor receptor (CSF-1R) and its ligand, CSF-1, correlates with invasiveness and poor prognosis of a variety of epithelial tumors (Kacinski, B.M. "
10/01/2003 - "IFN-gamma (>5 ng.ml(-1))(>400 IU.ml(-1)) inhibited the growth of bladder cancer cell lines and modified the expression of the tumor-associated markers tissue-type plasminogen activators, Plasminogen activator inhibitor-2, urokinase plasminogen activator receptor, colony-stimulating factor 1, intercellular adhesion molecule 1, and class II MHC. "
|2.||Schizophrenia (Dementia Praecox)
|3.||Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/01/1996 - "These results demonstrate that C/EBP and AML1 are important factors for regulating a critical hematopoietic growth factor receptor, the M-CSF receptor, suggesting a mechanism of how the AML1 fusion protein could contribute to acute myeloid leukemia. "
08/01/1989 - "Interleukin-3 and granulocyte-monocyte colony-stimulating factor receptors on human acute myelocytic leukemia cells and relationship to the proliferative response."
03/29/1996 - "The involvement of members of the PEBP2/CBF family in chromosome translocations associated with acute myeloid leukemia, and in the transcriptional regulation of the myeloid-specific genes encoding for myeloperoxidase, elastase, and the colony-stimulating factor receptor, highlights the relevance of the regulation of the CD36 gene promoter in monocytic cells by members of the PEBP2/CBF family."
|4.||Myeloproliferative Disorders (Myeloproliferative Disorder)
04/01/2007 - "A common point mutation in the JAK2 tyrosine kinase leads to constitutive hematopoietic growth factor receptor signaling and was recently described in many patients with myeloproliferative disorders (MPDs). "
06/01/2006 - "Recently, several groups identified a recurrent somatic point mutation constitutively activating the hematopoietic growth factor receptor-associated JAK2 tyrosine kinase in diverse chronic myeloid disorders - most commonly classic myeloproliferative disorders (MPD), especially polycythemia vera. "
|5.||Myeloid Leukemia (Leukemia, Myelocytic)
11/01/1996 - "The interaction of different members of the hematopoietic growth factor receptor family may be relevant to the increased proliferation and the failure of differentiation that characterizes the myeloid leukemias. "
01/01/1987 - "Primary human myeloid leukemia cells: comparative responsiveness to proliferative stimulation by GM-CSF or G-CSF and membrane expression of CSF receptors."
|2.||Macrophage Colony-Stimulating Factor
|3.||Protein-Tyrosine Kinases (Tyrosine Kinase)
|4.||Nerve Growth Factor (NGF)
|5.||Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)
|6.||Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
|7.||Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
|8.||Granulocyte Colony-Stimulating Factor (G-CSF)
|9.||Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
|10.||Urokinase-Type Plasminogen Activator (Urokinase)